; or (B) actionable information on the health and environmental impacts of ethylene oxide sterilization to government, industry, and members of the public. (6) Enabling of minimally disruptive conversion of exiting device sterilization facilities that use ethylene oxide to convert to less-toxic methods of sterilization. (c) Prize committees (1) In general The Director of the Center for Devices and Radiological Health shall assemble a prize committee with respect to each prize competition that shall define the scope and detail of, and provide the requirements for, the prize competitions under this section. Such committee shall be composed of— (A) members from the Federal agency, department, or office that most appropriately corresponds with the topic of the prize competition, including— (i) with respect to a prize competition under subsection (b)(1), the Director or designee of the National Institutes of Health; (ii) with respect to a prize competition under paragraphs (2), (3), (5), and (6) of subsection (b), the Director or designee of the National Science Foundation; and (iii) with respect to a prize competition under paragraphs (4) and (5) of subsection (b), the Administrator or designee of the Environmental Protection Agency; and (B) representatives of any other entities, as determined appropriate by the Director, including State and local governments and the private sector. (2) Defining topic areas The prize committee may modify and define the scope of the prize areas described under subsection (b), so long as such modification is in accordance with descriptions in such subsection. (3) Incentive for prize competition The prize committee for each prize competition shall determine the incentive for such prize competition. In determining the incentive, the committee may consider— (A) a cash prize; (B) access to Government facilities, a cooperative research and development agreement, or other method